XML 134 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION - Schedule of Options Outstanding and Weighted Average Exercise Price (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Number of Shares      
Options outstanding, beginning balance (in shares) 12,961,238 10,776,758  
Vested and exercisable, beginning balance (in shares) 6,742,890 6,188,200  
Granted (in shares) 3,038,000 4,575,641  
Exercised (in shares) (146,346) (25,518)  
Forfeited or expired (in shares) (728,346) (2,365,643)  
Options outstanding, ending balance (in shares) 15,124,546 12,961,238 10,776,758
Vested and exercisable, ending balance (in shares) 9,649,094 6,742,890 6,188,200
Weighted Average Exercise Price      
Options outstanding, beginning balance (in USD per share) $ 4.13 $ 4.97  
Vested and exercisable, beginning balance (in USD per share) 5.05 5.98  
Granted (in USD per share) 2.63 2.89  
Exercised (in USD per share) 2.76 1.91  
Forfeited or expired (in USD per share) 3.44 5.56  
Options outstanding, ending balance (in USD per share) 3.87 4.13 $ 4.97
Vested and exercisable, ending balance (in USD per share) $ 4.47 $ 5.05 $ 5.98
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted Average Remaining Contractual Life, Options outstanding (in years) 6 years 10 months 24 days 7 years 5 months 1 day 6 years 25 days
Weighted Average Remaining Contractual Life, Vested and exercisable (in years) 5 years 11 months 19 days 6 years 2 months 12 days 4 years 7 months 17 days
Weighted Average Remaining Contractual Life, Granted (in years) 9 years 2 months 12 days 9 years 3 months 3 days  
Aggregate Intrinsic Value, Options outstanding $ 5,212,586 $ 62,158 $ 2,389,890
Aggregate Intrinsic Value, Vested and exercisable $ 2,464,620 $ 61,214 $ 1,531,907